Katsuaki Maehara/X
Jul 14, 2024, 07:21
Drug list Ver 3 for mNSCLC: 1st line EGFR common mutations
Katsuaki Maehara, Director of Medical Education Colleagues, shared on X:
“Lung – NSCLC
Drug list Ver. 3
EGFR common mutations
( 1st line, Advanced / Metastatic )
Including data
- ELCC24
- AACR24
- ASCO24
EGFR TKIs monotherapy
Main clinical trials data
Subgroup and / or Biomarker analysis data
EGFR TKIs + VEGF-i and + Chemotherapies.”
Source: Katsuaki Maehara/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56